Soichi Kurioka

Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus

Ippei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 418 citations · Full text

Medicine, Endocrinology, Bone Metabolism +12

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus

Ippei Kanazawa, Toru Yamaguchi, Mika Yamauchi et al. · Osteoporosis International · 2010 · 242 citations

Medicine, Biochemistry, Endocrinology +14

Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes

Toru Yamaguchi, Ippei Kanazawa, Masahiro Yamamoto et al. · Bone · 2009 · 150 citations

Medicine, Endocrinology, Orthopedic Surgery +17

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Adiponectin Is Associated with Changes in Bone Markers during Glycemic Control in Type 2 Diabetes Mellitus

Ippei Kanazawa, Toru Yamaguchi, Mika Yamauchi et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 86 citations · Full text

Medicine, Biochemistry, Endocrinology +17